Sokbom J. Kang
Cancer Healthcare Research Branch
Goyang, Republic of Korea
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications
Natural radioactivity and radiological indices of slag, fly ash and mortar used in Korean construction.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
Published: May 21, 2026
Changes in the extensiveness of initial debulking surgery with increasing neoadjuvant chemotherapy use in advanced ovarian cancer: a nationwide population-based study.
Journal: Journal of gynecologic oncology
Published: December 21, 2025
Treatment patterns and survival outcomes according to histologic subtype in malignant ovarian germ cell tumors: a nationwide real-world cohort study.
Journal: Journal of gynecologic oncology
Published: August 27, 2025
Development and pilot testing of a personalised decision aid for decision-making regarding fertility preservation in young female patients with cancer: a study protocol.
Journal: BMJ open
Published: August 13, 2025
Comparative feasibility of reasoning and non-reasoning large language models for gynecologic cancer emergency care.
Journal: BMC health services research
Published: August 07, 2025
Volume over location: prioritizing case volume over regional distribution in ovarian cancer treatment.
Journal: Journal of gynecologic oncology
Published: June 24, 2025
Landscape of genomic alterations and clinical outcomes in low-grade serous ovarian cancer in Korea.
Journal: Gynecologic oncology reports
Published: June 17, 2025
Factors influencing decision-making on opportunistic salpingo-oophorectomy for ovarian cancer prevention in women with gastrointestinal cancers undergoing intra-abdominal surgery.
Journal: Gynecologic oncology reports
Published: May 19, 2025
Knowledge and personal values on fertility preservation procedures in Korean women.
Journal: PloS one
Published: May 19, 2025
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: April 16, 2025
Last Updated: 09/26/2026